The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Professional Services 72 - Scientific research and development 72.1 - Research and experimental development on natural sciences and engineering 72.10 - Research and experimental development on natural sciences and engineering
300 jobs Number of planned job losses
Announcement Date
8 January 2025
Employment effect (start)
1 February 2025
Foreseen end date
Description
Galapagos, a Belgian multinational biotech company has announced that it will cut 300 jobs worldwide.
The restructuring measures will affect employees in France, Switzerland, the Netherlands and Belgium. In total 300 employees will potentially face dismissal, approximately 200 of which in Belgium GALAPAGOS-2025-BE . The source also reports that the unit in France is expected to be closed. As required by law, the information and consultation phase between the company management and trade unions has been initiated.
The restructuring will divide the company into different sub-entities. The new company next to Galapagos is provisionally called SpinCo. All Galapagos shareholders will receive SpinCo shares according to how many Galapagos shares they hold. Additionally, some activities will be sold off to other companies, leading to dismissals as well.
Founded in 1999, Galapagos operates in the US, the Netherlands, France, Switzerland, and the UK. Galapagos is headquartered in Mechelen, Belgium. The Galapagos group currently has 1,489 employees.